Related Experiment Video
Updated: Jun 10, 2026

A Colorimetric Assay that Specifically Measures Granzyme B Proteolytic Activity: Hydrolysis of Boc-Ala-Ala-Asp-S-Bzl
Published on: November 28, 2014
Identifying Negative Biomarkers of CD4 Cytotoxic T Lymphocytes via Granzyme B Exclusion Analysis
Bingsu Wang1,2, Ayibaota Bahabayi3, Danyi Huang1,2
1Department of Immunology, NHC Key Laboratory of Medical Immunology (Peking University), Medicine Innovation Center for Fundamental Research on Major Immunology-related Diseases, School of Basic Medical Sciences, Peking University Health Science Center, Beijing, China.
None:
CD4 cytotoxic T lymphocytes (CTLs) are a distinct subset of CD4+ T cells that can mediate antigen-specific cytotoxicity. However, their specific surface markers have yet to be defined. In this study, we used gene-plasticity-based mutual exclusion analysis to identify negative biomarkers for CD4 CTLs, using granzyme B (GZMB) expression as the pivotal reference. We analyzed bulk RNA-seq data from 768 human CD4+ T cell samples, calculated gene plasticity scores, and applied cosine similarity to detect genes that are anti-correlated with GZMB. Several genes encoding cell surface membrane proteins were identified as important candidates. ITGA6 (CD49f) and IL6R (CD126) were validated by flow cytometry in healthy individuals and primary Sjögren's syndrome (pSS) patients. The expression profile confirmed mutually exclusive between GZMB and both CD49f and CD126, with CD49f-CD126-GPR56+ CD4+ T cells exhibiting the highest GZMB levels. In pSS patients, CD49f-CD126-GPR56+ cells in CD8+ T cells were significantly negatively correlated with clinical parameters (IgA, anti-SSB). ROC analysis revealed the percentages of GZMB in CD4+ T cells (AUC = 0.766) and GPR56/GZMB in CD8+ T cells (AUC = 0.76) as diagnostic biomarkers.

